Life Sciences Group Of The Year: Cooley
Representing a clinical-stage life sciences company in its $6.7 billion sale to Pfizer and shepherding a cancer drugmaker's $4.1 billion acquisition by Bristol-Myers Squibb are among the achievements that made Cooley...To view the full article, register now.
Already a subscriber? Click here to view full article